Exenatide May Be as Effective as Insulin Glargine in Type 2 Diabetes Mellitus
20th Oct 2005, 11:33 GMT
In an open-label, randomized trial, exenatide was also associated with weight reduction but had a higher incidence of gastrointestinal tract adverse effects than insulin glargine. (CME) Medscape Medical News Charles Vega,Gary Vogin,Laurie Barclay